StartupFundraising.com
Facts
- Sectors
- AI, SaaS, Fundraising
- Founded
- 2023
- Founders
- Alejandro Cremades
Is this your organization? Claim it
Bardy Diagnostics Reveals $375M Total Funding; $36M Series B Recorded in April 2019
Bardy Diagnostics, headquartered in New Providence, NJ, has disclosed $375M in total funding, with its latest recorded round a $36M Series B in April 2019. The company’s leadership links to Baxter International via Andrew Hider, and investors include River Cities Capital Funds, HealthQuest Capital, Aperture Venture Partners, and others.
Group14 Technologies Raises $463M in Series D, Bringing Total Funding to $1B
Group14 Technologies, a Woodinville-based climate company led by co-founder & CEO Rick Luebbe, has raised $1B in total disclosed funding, most recently a $463M Series D in August 2024. Investors include Porsche AG, SK Group, Microsoft Climate Innovation Fund, OMERS, Riverstone, BASF, Cabot, and others.
OncoResponse raises $150M total, closes $6M Series D in April 2025; backed by ARE, Rice University, Takeda
OncoResponse, headquartered in Seattle, has raised $150M total with a recorded $6M Series D round in April 2025 and is backed by investors including ARE, Rice University, and Takeda Pharmaceuticals.
Ally.io raises $50M Series C, bringing total funding to $76M; investors include Accel, Addition, GreenOaks
Ally.io, a Seattle-based company led by co-founder & CEO Vetri Vellore, has raised $76M total with a $50M Series C as its most recent round in February 2021, backed by investors including Accel, Addition, and GreenOaks.
People
-
Alejandro Cremades Founder & CEO